AI

Executives pointed to faster-than-expected AI adoption in healthcare, shifting regulatory signals and growing demand for AI tools that deliver measurable outcomes.

The Australian research, which aims to help people with motor neuron disease keep moving, is now testing AI to personalise assistance.

Arintra CEO Nitesh Shroff says the company's AI-powered platform turns complex clinical documentation into explainable, compliant codes that help reduce claim denials and support improving health systems' bottom lines.

Dr. Doug Fridsma, former ONC chief science officer and current CMIO at Health Universe, discusses the challenges of AI in healthcare and balancing innovation with privacy, safety and regulation.

The executive order says it revokes attempts to paralyze the AI industry and establishes an AI Litigation Task Force to challenge state AI laws inconsistent with national policy.

Sandra Johnson, CliniComp senior vice president, says keeping data in a single longitudinal system makes it easier to prove AI's positive impact on metrics such as shorter stays, fewer readmissions and higher patient satisfaction.

Genentech will leverage Medra's Physical AI, Scientific AI and robotics into its lab systems to accelerate drug discovery.

Respiree is also preparing to file for regulatory approval for its AI tool in the United States and across Australia, New Zealand, and Asia.

Screening rates in northern Queensland lag behind the statewide average.

The LLM-based tool, developed by researchers from Yonsei University College of Medicine, automatically generates legally required discharge notes in the emergency department.